The Global Human Insulin Market to Surge at a CAGR of 8.1% and Is Projected to Reach USD 39.13 Billion by 2020

Press Release   •   Jan 19, 2017 05:04 EST

The global human insulin market is poised to reach ~USD 39.13 Billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of market. In addition, high product manufacturing costs is posing significant challenges for market growth.

On the basis of product, the human insulin market is classified into two major segments— drugs and delivery devices. Human insulin drugs segment is expected to account for the largest share of the global market, by product, in 2015. Its large share is propelled by factors such as increasing diabetic population across globe, growing R&D for drug discovery & development, rising proportion of aging population in developed countries, increasing market accessibility of generic human insulin products worldwide, and rising government initiatives to support the development and commercialization of effective biosimilars.

Full details of this report are available at http://www.rnrmarketresearch.com/human-insulin-market-by-product-type-human-insulin-short-acting-intermediate-acting-premixed-modern-human-insulin-rapid-acting-long-acting-premixed-by-brand-lantus-apidra-levemir-novora-market-report.html

On the basis of product type, the human insulin delivery devices market is classified into three segments—pens, pen needles, and syringes. The pens segment is expected to account for the largest market share in 2015; it is poised to be the fastest-growing segment during the next five years. Its high growth can be attributed to growing market focus of pen manufacturers on emerging countries such as China, India, & Brazil; significant medical reimbursements offered for human insulin pens across mature markets such as the U.S. & Europe; and continuous pipeline development & product commercialization of innovative human insulin pens.

Geographically, the market is classified into four regions—North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

Inquire about this report: http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=192775

Geography expansion and product development are the key strategies adopted by major players to strengthen their positions in the global market. Moreover, strategies such as partnerships, agreements, collaborations, awareness campaigns, and research funding & grants were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global human insulin market.

Sanofi (France), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (U.A.E.), Ypsomed AG (Switzerland), Becton, Dickinson and Company (U.S.), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.) are few of the key players operating in the global human insulin market.

Executive Summary: Current Market Scenario, Future Outlook, Conclusion

Premium Insights: Global Market (2015–2020), Global Market Size, By Product (2015), Global HI Drugs Market Size, By Product Type (2015-2020), Global HI Drugs Market Size, By Brand (2014), Global HI Delivery Devices Market Size, By Type (2015-2020), Global Market Size, By Region (2015-2020)

Request a sample Copy of This Report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=192775

Gist of Table of Content

Market Overview: Market Segmentation, Market Evolution, Market Dynamics, Key Market Drivers, Growth in the Number of Diabetic Patients, Increasing Population Exposure to Key Risk Factors Leading to Diabetes, Rising Market Demand for HI Analogs, Technological Advancements in HI Delivery Devices, Favorable Medical Reimbursement Scenario in Developed Countries, Key Market Restraints, Stringent Regulatory Requirements for Product Approval, Key Market Opportunities, Emerging Markets, Expected Patent Expiry of Key HI Drugs, Key Market Challenge, High Product Manufacturing Costs

Industry Insights, Introduction, Industry Trends, Growing Market Demand for HI Pens, Increasing Market Focus on the Pipeline Development of Novel Human Insulin Therapies, Pipeline Analysis, By Company, By Clinical Trial Phase, Porter’s Five Force Analysis, Threat From New Entrants, Threat From Substitutes, Bargaining Power of Buyers, Bargaining Power of Suppliers, Intensity of Competitive Rivalry

Global Human Insulin Market, By Product Type: HI Drugs, HI Delivery Devices By Type, Insulin Analogs and Biosimilars, Long-Acting Biosimilars, Rapid-Acting Biosimilars, Premixed Biosimilars, HI Biologics, Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics By Brand, HI Analogs and Biosimilars, Lantus, Novorapid and Novolog, Humalog, Other Brands, HI Biologics, Actrapid, Mixtard, and Insulatard, Humulin, Insuman

Global Human Insulin Market, By Delivery Devices: Syringes, Pens, Disposable Pens, Reusable Pens, Pen Needles, Standard Pen Needles, Safety Pen Needles By Application: Type I Diabetes, Type II Diabetes By Region, North America, U.S., Canada, Europe, Germany, France, U.K., Rest of Europe (RoE), Asia-Pacific (APAC) Japan, China, India, Rest of Asia-Pacific (RoAPAC), Rest of the World (RoW)

Global Human Insulin Market Competitive Landscape: Overview, Market Share Analysis, HI Drugs Market, HI Delivery Devices Market, Competitive Scenario, Recent Developments, Geographical Expansions, Agreements, Collaborations, and Partnerships, New Product Launches, Awareness Programs, Funding & Scholarships, Strategic Acquisitions

Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

RnR Market Research

Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+ 1 888 391 5441